Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas

被引:62
作者
Huyett, Lauren M. [1 ]
Dassau, Eyal [1 ]
Zisser, Howard C. [1 ]
Doyle, Francis J., III [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
INSULIN-PUMP THERAPY; CLOSED-LOOP SYSTEM; SUBCUTANEOUS INSULIN; GLYCEMIC CONTROL; INTRAPERITONEAL; GLUCOSE; DELIVERY; INFUSION; HYPOGLYCEMIA; FEASIBILITY;
D O I
10.1021/acs.iecr.5b01237
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Treatment of type 1 diabetes mellitus could be greatly improved by applying a closed-loop control strategy to insulin delivery, also known as an artificial pancreas (AP). In this work, we outline the design of a fully implantable AP using intraperitoneal (IP) insulin delivery and glucose sensing. The design process utilizes the rapid glucose sensing and insulin action offered by the IP space to tune a PM controller with insulin feedback to provide safe and effective insulin delivery. The controller was tuned to meet robust performance and stability specifications. An anti-reset windup strategy was introduced to prevent dangerous undershoot toward hypoglycemia after a large meal disturbance. The final controller design achieved 78% of time within the tight glycemic range of 80-140 mg/dL, with no time spent in hypoglycemia. The next step is to test this controller design in an animal model to evaluate the in vivo performance.
引用
收藏
页码:10311 / 10321
页数:11
相关论文
共 53 条
  • [21] Automated Control of an Adaptive Bihormonal, Dual-Sensor Artificial Pancreas and Evaluation During Inpatient Studies
    Jacobs, Peter G.
    El Youssef, Joseph
    Castle, Jessica
    Bakhtiani, Parkash
    Branigan, Deborah
    Breen, Matthew
    Bauer, David
    Preiser, Nicholas
    Leonard, Gerald
    Stonex, Tara
    Ward, W. Kenneth
    [J]. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2014, 61 (10) : 2569 - 2581
  • [22] Keenan D Barry, 2009, J Diabetes Sci Technol, V3, P1207
  • [23] Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44
  • [24] Laxminarayan Srinivas, 2012, J Diabetes Sci Technol, V6, P1401
  • [25] Lee JB, 2013, P AMER CONTR CONF, P2911
  • [26] Lee JJ, 2013, IEEE DECIS CONTR P, P127, DOI 10.1109/CDC.2013.6759870
  • [27] Design and in silico evaluation of an intraperitoneal-subcutaneous (IP-SC) artificial pancreas
    Lee, Justin J.
    Dassau, Eyal
    Zisser, Howard
    Doyle, Francis J., III
    [J]. COMPUTERS & CHEMICAL ENGINEERING, 2014, 70 : 180 - 188
  • [28] A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion
    Liebl, A.
    Hoogma, R.
    Renard, E.
    Geelhoed-Duijvestijn, P. H. L. M.
    Klein, E.
    Diglas, J.
    Kessler, L.
    Melki, V.
    Diem, P.
    Brun, J. -M.
    Schaepelynck-Belicar, P.
    Frei, T.
    [J]. DIABETES OBESITY & METABOLISM, 2009, 11 (11) : 1001 - 1008
  • [29] Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes
    Logtenberg, Susan J.
    Kleefstra, Nanne
    Houweling, Sebastiaan T.
    Groenier, Klaas H.
    Gans, Reinold O.
    Bilo, Henk J.
    [J]. DIABETES CARE, 2010, 33 (06) : 1169 - 1172
  • [30] Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes A randomized controlled trial
    Logtenberg, Susan J.
    Kleefstra, Nanne
    Houweling, Sebastiaan T.
    Groenier, Klaas H.
    Gans, Reinold O.
    van Ballegooie, Evert
    Bilo, Henk J.
    [J]. DIABETES CARE, 2009, 32 (08) : 1372 - 1377